期刊文献+

B型利钠肽与心肾综合征相关性的研究进展 被引量:4

下载PDF
导出
摘要 心功能不全与肾功能不全常同时存在于一个患者中,被称为“心肾综合征(cardiorenal syndrome,CRS)。流行病学证据显示即使轻度的肾功能受损也能使心力衰竭患者的预后更差,且给治疗带来很大的困惑。因此,心肾综合征近年来备受关注。
出处 《医学临床研究》 CAS 2009年第2期349-351,共3页 Journal of Clinical Research
  • 相关文献

参考文献22

  • 1McAlister FA, Ezekowitz J, Tonelli M, et al . Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study[J]. Circulation ,2004, 109(8) :1004-1009.
  • 2Boerrigter G and Burnett JC. Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications[J]. Curr Heart Fail Rep ,2004,1(3) : 113-120.
  • 3Heywood JT . The cardiorenal syndrome: lessons from the ADHERE database and treatment options[J]. Heart Fail Rev ,2004,9(3) : 195-201.
  • 4McCullough PA and Sandberg KR. Sorting out the evidence on natriuretic peptides[J]. Rev Cardiovasc Med ,2003,4(4) : S13- S19.
  • 5Roland RJ, van Kimmenade, James L, et al . Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure Redefining the Cardiorenal Interaction [ J ]? Journal of the American College of Cardiology , 2006,48(8) :1621- 1627.
  • 6McCullough PA, Kuncheria J and Mathur VS. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure[J]. Rev Cardiovasc IVied ,2004,5(1) :16-25.
  • 7Joles A and Koomans HA. Causes and consequences of increased sympathetic activity in renal disease [ J ]. Hypertension , 2004,43(4) : 699-706.
  • 8Chen HH, Burnett JC. Clinical application of the natriuretic peptides in heart failure[J]. Eur Heart J ,2006,8(Suppl E) : E18-E25.
  • 9Potter LR, Abbey-Hosch S; Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphatedependent signaling functions[J]. Endocr Rev , 2006,27 (1) : 47-72.
  • 10Cody R J, Atlas SA, Laragh JH, et al . Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal. hormonal, and hemodynamic responses to peptide infusion[J]. J Clin Invest , 1986,78(5) : 1362-1374.

二级参考文献45

  • 1汤永谦,张海蓉,王艳,陶红,沈青山,刘文卫,成蓓.心力衰竭患者脑钠素水平与6min步行试验相关性研究[J].临床心血管病杂志,2005,21(10):586-587. 被引量:9
  • 2Dickstein K. Natriuretic peptides in detection of heart failure [J]. Lancet, 1998,35:3 -4.
  • 3Zhu W X,Johnson S B,Brandt R,et al. Impact of volume loading and load reduction on ventricular refractoriness and conduction properties on canine congestive heart failure [J]. J Am Coll Cardiol, 1997,30 : 825 - 833.
  • 4Colucci W S,Elkayam U, Horton D P, et al. Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated congestive heart failure[J]. N Eng J Med,2000,343:246 - 253.
  • 5de Lemos J A, David A M. Brain natriuretic peptide measurement in acutecoronary syndromes ready for clinical application [J] ? Circulation, 2002, 106 :2868 - 2870.
  • 6Maisel A S, Krishnaswamy P,Nowak RM,et al. Rapid measurement of B -type natriuretic peptide in the emergency diagnosis of heart failure [J]. N Eng J Med,2002,347:161 - 167.
  • 7Maeda K, Tsuamoto T, Wada A, et al.High levels of plasma brain natriuretic peptide and interleukin - 6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure [ J]. J Am Coll Cardiol,2002,36: 1587 - 1593.
  • 8Katherine L,Morrison B S,Alex Harrison B S,et al. Utility of a rapid B - natri-uretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea[J]. J Am Coll Cardiol, 2002,39:202 -209.
  • 9Davis M, Espiner E, Richards G, et al.Plasma brain natriuretic peptide in assessment of acute dyspnea [J]. Lancet,1998,343: 440 - 444.
  • 10Dao Quyen, Padma K, Radmila K, et al.Utility of B - type natriuretic peptide in the diagnosis of congestive heart failurein an urgent -care setting[J]. J Am Coll Cardiol, 2001,37 : 379 - 385.

共引文献123

同被引文献27

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部